Targeting FcRn for therapy: from modulating IgG levels to tumor metabolismTuesday, 7 March 2017 at 10:00 Add to Calendar ▼2017-03-06 00:00:002017-03-06 01:00:00Europe/LondonEngineering Antibodies to Modulate their Spatiotemporal BehaviorAdvances in Drug Discovery in Wellcome Genome Campus Conference Centre, Cambridge, UKWellcome Genome Campus Conference Centre, Cambridge, UKSELECTBIOenquiries@selectbiosciences.com Through its recycling activity, FcRn controls the levels of IgG and albumin in the body. Recent studies involving the modulation of IgG levels for diagnosis and therapy, combined with the identification of FcRn as a metabolic regulator, will be presented. |